Home > Financial Ratios > LYKA LABS

LYKA LABS
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 6.668.638.02-4.12-4.15

What is the latest Working Capital/Sales ratio of LYKA LABS ?

The latest Working Capital/Sales ratio of LYKA LABS is 6.66 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20256.66
Mar20248.63
Mar20238.02
Mar2022-4.12
Mar2021-4.15

How is Working Capital/Sales of LYKA LABS Trending?

Years Working Capital/Sales % Change
Mar2025 6.66
-22.83
Mar2024 8.63
7.61
Mar2023 8.02
Positive
Mar2022 -4.12
Negative
Mar2021 -4.15 -

Other Financial Ratios of LYKA LABS


Compare Working Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹277.7 Cr -3.8% -1.2% -49.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,037.0 Cr -1.3% -3.9% -5.8% Stock Analytics
DIVIS LABORATORIES ₹170,795.0 Cr -2.3% 0.9% 12.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,332.0 Cr 0.3% 3.9% 19.2% Stock Analytics
CIPLA ₹116,933.0 Cr -4.2% -3.1% -1.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,350.2 Cr -3.2% -4.5% -11.8% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-3.8%

-1.2%

-49.2%

SENSEX

-1.8%

-0.6%

7.3%


You may also like the below Video Courses